Scientific Programme

Friday November 26, 2021

Central European Time - CET

- This is a preliminary programme, speakers and chairs could be changed until the programme is definitive -

09.00—09.10

CONGRESS OPENING

→ Welcome by EMLTD president
Alexandros Tselepis (Greece)

→ EMLTD: Past-Present-Future
Lina Badimon (Spain)

09.10—09.30

KEYNOTE LECTURE I

Chairs
Lina Badimon (Spain)

→ Deep Learning and Artificial Intelligence
Panos Vardas (Greece)

09.30—10.30

STATE OF THE ART SESSION.
COVID-19, Vaccines and Thrombosis Risk. Underlying Mechanisms and Management

Chairs
Eugene Roitman (Russia)
Alexandros Tselepis (Greece)

→ The unique characteristics of COVID-19 coagulopathy
Joan Carles Reverter (Spain)

→ Prevention of thrombosis on COVID-19 patients.
Alex Spyropoulos (USA)

→ KEYNOTE LECTURE. Vaccine-induced Thrombotic Thrombocytopenia. Possible Mechanisms and Real-World Data.
Andreas Greinacher (Germany)

10.30—11.30

MEET THE EXPERTS.
Antithrombotics in patients with intracardiac devices

Chairs
Joao Morais (Portugal)
Cherif Abdelkhirane (Morocco)

→ Bioprosthetic valves and subclinical risk of thrombosis
Gregory Pattakos (Greece)

→ TAVI
Jurien Ten Berg (The Netherlands)

→ Left atrial appendage closure
Michael Glikson (Israel)

11.30—12.30

HOW TO TREAT.
DOACS in pediatric medicine

Chairs
Ulrike Nowak Gottl (Germany)
David Varon (Israel)

→ Treatment of pediatric VTE- is the standard of care changing?
Gili Kenet (Israel)

→ Bleeding and thrombosis- treatment challenges for pediatric patients on DOAC therapy
Cornelia Heleen van Ommen (The Netherlands)

12.30—13.30

Break

13.30—14.30

EMLTD General Assembly

14.30—15.30

WORKSHOP.
The challenges of bleeding in antithrombotic treatment

Chairs
James Douketis (Canada)
Neophytos Zambas (Cyprus)

→ How to resume antithrombotics after major bleeding
Sigrun Halvorsen (Norway)

→ DOAC antidotes. When should we use them?
Vittorio Pengo (Italy)

→ Antithrombotics in stented patients with an indication for oral anticoagulants
Andrea Rubolli (Italy)

15.30—16.30

CLINICAL SEMINAR.
Ischemic stroke prevention in patients with atrial fibrillation

Chairs
Charalampos Milionis (Greece)
Sophia Vassilopoulou (Greece)

→ The burden of atrial fibrillation: effectiveness and safety of DOACs
Konstantinos Siontis (USA)

→ Left appendage closure: Why, when and to whom
Eduardo Olivera (Portugal)

→ New devices to uncover silent atrial fibrillation
Gentian Denas (Italy)

16.30—17.30

STATE OF THE ART SESSION.
New Insights in Cancer-Associated Thrombosis

Chairs
Vittorio Pengo (Italy)
Grigoris Gerotziafas (France)

→ Mechanisms and biomarkers of cancer-associated thrombosis
Alok Khorana (USA)

→ Deep vein thrombosis and pulmonary embolism in cancer patients
Anna Falanga (Italy)

→ Management of VTE in cancer patients: lessons from real life practice
Manel Monreal (Spain)

Logo-Bco-02

TECHNICAL SECRETARIAT

Pl. Europa, 17-19 1ª planta
08908 L’Hospitalet de Llobregat
Barcelona – España
+34 93 882 38 78

ORGANIZED BY